These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7092920)

  • 1. Inhibition of rat liver monoamine oxidase by alpha-methyl- and N-propargyl-amine derivatives.
    Tipton KF; McCrodden JM; Kalir AS; Youdim MB
    Biochem Pharmacol; 1982 Apr; 31(7):1251-5. PubMed ID: 7092920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics of monoamine oxidase inhibition by three 2-indolylmethylamine derivatives.
    Cruces MA; Elorriaga C; Fernández-Alvarez E
    Biochem Pharmacol; 1990 Aug; 40(3):535-43. PubMed ID: 2383286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of structural modification of alkyl N-propargylamines on the selective inhibition of monoamine oxidase B activity.
    Yu PH; Davis BA; Boulton AA
    Biochem Pharmacol; 1993 Aug; 46(4):753-7. PubMed ID: 8363648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective acetylenic 'suicide' and reversible inhibitors of monoamine oxidase types A and B.
    Kalir A; Sabbagh A; Youdim MB
    Br J Pharmacol; 1981 May; 73(1):55-64. PubMed ID: 7284698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inversion of selectivity of N-substituted propargylamine monoamine oxidase inhibitors following structural modifications to quaternary salts.
    Yu PH; Davis BA
    Int J Biochem Cell Biol; 1999 Dec; 31(12):1391-7. PubMed ID: 10641793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and inactivation of monoamine oxidase by 3-amino-1-phenyl-prop-1-enes.
    Williams CH; Lawson J; Backwell FR
    Biochim Biophys Acta; 1992 Feb; 1119(2):111-7. PubMed ID: 1540641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes.
    Houslay MD; Tipton KF
    Biochem J; 1974 Jun; 139(3):645-52. PubMed ID: 4850215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase. II. Time-dependent inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1974 Feb; 23(3):629-36. PubMed ID: 4822747
    [No Abstract]   [Full Text] [Related]  

  • 10. The inhibition of rat liver mitochondrial monoamine oxidase by 2-bromo-2-phenylacetaldehyde.
    Tipton KF
    Biochem Pharmacol; 1969 Oct; 18(10):2559-61. PubMed ID: 5403991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
    Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
    Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitory potencies and selectivities of 2-[N-(2-propynyl)-aminomethyl]-1-methyl indole derivatives.
    Balsa D; Fernandez-Alverez E; Tipton KF; Unzeta M
    Biochem Soc Trans; 1991 Feb; 19(1):215-8. PubMed ID: 2037154
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition by clorgyline and deprenyl of the different forms of monoamine oxidase in rat liver mitochondria.
    Egashira T; Ekstedt B; Oreland L
    Biochem Pharmacol; 1976 Dec; 25(23):2583-6. PubMed ID: 985579
    [No Abstract]   [Full Text] [Related]  

  • 14. Observations on the inhibition of rat liver monoamine oxidase by clorgyline.
    Lyles GA; Greenawalt JW
    Biochem Pharmacol; 1977 Dec; 26(23):2269-74. PubMed ID: 588309
    [No Abstract]   [Full Text] [Related]  

  • 15. The inhibition of rat brain monoamine oxidase-B by J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride), and its use for the titration of this enzyme form.
    Fowler CJ; Oreland L; Wiberg A; Carlsson A; Magnusson T
    Med Biol; 1979; 57(6):406-11. PubMed ID: 547123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 17. Titration of human brain type-B monoamine oxidase.
    Fowler CJ; Wiberg A; Oreland L; Winblad B
    Neurochem Res; 1980 Jul; 5(7):697-708. PubMed ID: 7422056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compounds with potential enzyme inhibitory acitivity. Hydroxylamine analogs of 2-propynylamine.
    Moore DH; Cannon JG; McIsaac WM; Ho BT
    J Med Chem; 1969 Jan; 12(1):45-8. PubMed ID: 5304104
    [No Abstract]   [Full Text] [Related]  

  • 19. The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-(4-[(3-chlorophenyl)methoxy]phenyl)-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactions.
    Tipton KF; Fowler CJ; McCrodden JM; Strolin Benedetti M
    Biochem J; 1983 Jan; 209(1):235-42. PubMed ID: 6847610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.